Development and Validation of Case‐Finding Algorithms to Identify Periprosthetic Joint Infections After Total Hip Arthroplasty in Veterans Health Administration Data

Read full text
Authors: Jessica C O’Neil, Yixuan Amy Pei, Craig W. Newcomb, Randi Silibovsky, Judith A. O’Donnell, Charles L. Nelson, Evelyn Hsieh, Joseph T. King, Stephen Crystal, Jennifer S. Hanberg, Vincent Lo Re, Erica J. Weinstein
Cited by: 1
References: 23

Abstract

PURPOSE: To determine the positive predictive values (PPVs) of ICD-9- and ICD-10-based diagnostic coding algorithms to identify periprosthetic joint infection (PJI) following total hip arthroplasty (THA) within the United States (US) Veterans Health Administration (VHA). METHODS: We selected patients with: (1) any position hospital discharge ICD-9 or ICD-10 diagnosis of PJI, (2) ICD-9, ICD-10, or current procedural terminology (CPT) procedure codes for THA any time prior to PJI diagnosis, (3) CPT code for hip X-ray within ±90 days of the PJI diagnosis, and (4) 1 or more CPT codes for arthrocentesis, arthrotomy, or revision arthroplasty all occurring within ±90 days of the PJI diagnosis date. We obtained separate samples of patients for ICD-9 and ICD-10-based PJI diagnoses. These samples were stratified by THA medical center volume. Infectious disease physicians adjudicated each identified PJI event. The PPV (95% confidence interval [CI]) for the ICD-9 and ICD-10 PJI algorithms were calculated. RESULTS: Among the 90 sampled hip PJI events for the ICD-9 era, 79 were confirmed PJIs (PPV 87.8%, 95% CI 79.2%-93.7%). For the 90 sampled hip PJI events for the ICD-10 era, 72 were confirmed PJIs (PPV 80.0%, 95% CI 70.3%-87.7%). CONCLUSION: These algorithms yielded a PPV of 87.8% (ICD-9) and 80.0% (ICD-10), for confirmed PJI events and could be considered for use in future pharmacoepidemiologic studies.

Fields of Study & Subjects

Orthopedic Infections and Treatments Orthopaedic implants and arthroplasty Total Knee Arthroplasty Outcomes

Publication details

Journal / source
Pharmacoepidemiology and Drug Safety
Publisher
Wiley
Volume
35
Issue
1
Pages
e70311–e70311
Publication date
1 January 2026
Language
EN